Join the PREG
Pregnancy Registry

Picture of pregnant woman

Join the study to help researchers, healthcare providers, and other patients learn about the safety of Blujepa (gepotidacin) during pregnancy, as well as other medications used for the treatment of uUTIs during pregnancy. A pregnancy registry is a study that collects health information from women who take prescription medications when they are pregnant.

Would you like to participate?

Contact the Registry today.

Register

Participation is voluntary and patients may withdraw from registry any time without affecting their medical care.

Consent to contact

Complete the Contact Request Form here and a registry team member will contact you

Email the registry team with your contact information at:

Call the registry team

Call the registry team toll-free at
1-866-609-1612 (hours of operation 8:30 AM - 5:00 PM EST Monday-Friday)

What is VOQUEZNA?

VOQUEZNA® (vonoprazan) is a prescription medicine used in adults:

  • for 8 weeks to heal acid-related damage to the lining of the esophagus (called Erosive Esophagitis) and for relief of heartburn related to Erosive Esophagitis.
  • for up to 6 months to maintain healing of Erosive Esophagitis and for relief of heartburn related to Erosive Esophagitis.
  • for 4 weeks for relief of heartburn related to gastroesophageal reflux disease (GERD).
  • for 14 days with the antibiotics amoxicillin and clarithromycin to treat an infection caused by bacteria called Helicobacter pylori (H. pylori)
  • for 14 days with the antibiotic amoxicillin to treat an infection caused by bacteria called H. pylori.

It is not known if VOQUEZNA is safe and effective in children.

  • VOQUEZNA® TRIPLE PAK® (vonoprazan tablets, amoxicillin capsules, clarithromycin tablets) and VOQUEZNA® DUAL PAK® (vonoprazan tablets, amoxicillin capsules) are co-packaged prescription medicines for the treatment of a Helicobacter pylori (H. pylori) bacterial infection in adults.
  • It is not known if VOQUEZNA TRIPLE PAK and VOQUEZNA DUAL PAK are safe and effective in children.
  • To reduce the development of drug-resistant bacteria and maintain the effectiveness of VOQUEZNA TRIPLE PAK, VOQUEZNA DUAL PAK and other antibacterial drugs, these products should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria.

Future pregnant women with Non-Erosive GERD, Erosive GERD, or H. pylori infection, their healthcare providers, and researchers can benefit from the information you provide to the registry.

If you are eligible and would like to participate, you will be asked to:

  1. Provide your consent (a requirement for participation in any research study)
  2. Give the registry permission to contact your healthcare provider(s) to collect information for the study

You and your healthcare provider(s) will provide information to the registry about your pregnancy and your baby’s health up to 1 year of age. This information can be provided by completing paper forms, via the website portal or via short phone interviews with one of the registry staff members. Only information normally documented in your medical record will be collected.

If you participate, there will be:

  • No extra doctor’s visits or additional testing
  • No changes to your existing healthcare provider(s) or care

You and your healthcare provider(s) will receive compensation for providing data to the registry.

If you are eligible and would like to participate, you will be asked to provide information to the registry at enrollment and may provide additional information periodically throughout your pregnancy:

  • At enrollment, you will be asked to provide basic information about yourself (e.g., race, ethnicity, education, height, and weight) and information about your history of Non-Erosive GERD, Erosive GERD, or H. pylori infection.
  • Throughout pregnancy, specifically at the end of the second trimester, shortly after birth, and at 4 and 12 months after a live birth, you may be asked to provide additional information about your pregnancy and your baby.

You will receive compensation for providing data to the registry.

Would you like to participate?

Enroll in the Registry

Important Safety Information: Blujepa/gepotidacin

What is the most important information I should know about BLUJEPA?

BLUJEPA, an antibiotic, can cause serious side effects, including:

changes in electrical activity of your heart called QTc prolongation. BLUJEPA can cause QTc prolongation (also called prolonged QTc interval) that can lead to serious heart rhythm problems, including Torsades de Pointes. There may be changes in your heartbeat (a fast or irregular heartbeat).

Before starting BLUJEPA, tell your healthcare provider if you:

  • or anyone in your family has ever had a heart rhythm problem (problem with heart rate or heartbeat) or QTc prolongation.
  • are taking any medicines to treat heart rhythm problems. Using these medicines with BLUJEPA may cause serious side effects. If you are not sure, ask your healthcare provider.
  • are taking medicines called moderate or strong CYP3A4 inhibitors. Using these medicines with BLUJEPA may cause serious side effects. If you are not sure, ask your healthcare provider.

Tell your healthcare provider right away if you have any of the following symptoms:

  • fast, pounding, or uneven heartbeat
  • feeling dizzy
  • you lose consciousness (pass out)
  • feeling lightheaded
  • feeling faint
  • an increase of a certain chemical in your nervous system (cholinergic effects). BLUJEPA can cause an increase of a certain chemical in your nervous system, which may cause the following symptoms:
    • diarrhea
    • vomiting
    • fainting
    • trouble saying words clearly
    • muscle spasms
    • nausea
    • more saliva in the mouth
    • more sweating
    • stomach pain
Call your healthcare provider right away if you have trouble saying words clearly, have shortness of breath, or if you faint. These symptoms may be cholinergic effects of BLUJEPA. The increased chemical in your nervous system can also be connected to other symptoms. Call your healthcare provider right away if you have any of these additional symptoms: - irregular heartbeat (heart block) - slow heartbeat (bradycardia) - seizures - fainting - chest tightness causing difficulty breathing · allergic reactions. Allergic reactions can happen in people who take BLUJEPA, including a severe allergic reaction called anaphylaxis. Stop taking BLUJEPA and get medical help right away if you have any symptoms of a severe allergic reaction, including: - hives - feeling faint or dizzy - rash - swelling of your lips, tongue, or throat · diarrhea. Diarrhea is a common side effect caused by antibiotics including BLUJEPA. The diarrhea may happen at the beginning of your treatment with BLUJEPA and usually stops after the antibiotic is stopped. In most cases, the diarrhea will go away without treatment. In some cases, diarrhea may be caused by Clostridioides difficile infection (CDI). CDI is a severe infection of the intestines (bowels) that can happen up to 2 months after finishing treatment with antibiotic medicines, including BLUJEPA. CDI can be life-threatening and can lead to death. Do not take medicines to treat diarrhea without first checking with your healthcare provider. Call your healthcare provider right away if you have the following symptoms: - stomach cramps - fever - watery diarrhea - diarrhea that does not go away - bloody stools Who should not take BLUJEPA? Do not take BLUJEPA if: you have had a severe allergic reaction to BLUJEPA. Before taking BLUJEPA, tell your healthcare provider about all of your medical conditions, including if you: - have heart rhythm problems. See “What is the most important information I should know about BLUJEPA?” - have a slow heartbeat (bradycardia) - have recently had a heart attack - have low potassium in your blood (hypokalemia) - are planning to have a medical or surgical procedure that puts you to sleep (general anesthesia) that will use a type of medicine given through your veins (IV) that relaxes your muscles - have liver problems - have kidney problems, kidney failure, or are on dialysis - are pregnant or plan to become pregnant. It is not known if BLUJEPA will harm your unborn baby Tell your healthcare provider if you become pregnant or think you are pregnant during your treatment with BLUJEPA - Pregnancy Exposure Registry: There is a pregnancy exposure registry for those who are exposed to BLUJEPA during pregnancy. Talk to your healthcare provider about registering with GlaxoSmithKline. You can register by calling 1-888-825-5249 - are breastfeeding or plan to breastfeed. It is not known if BLUJEPA passes into breast milk. Talk to your healthcare provider about the best way to feed your baby during your treatment with BLUJEPA Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. BLUJEPA and other medicines may affect each other, causing side effects. Especially tell your healthcare provider if you take medicines to treat heart rhythm problems. Ask your healthcare provider or pharmacist if you are not sure if you are taking any of these medicines. Know the medicines you take. Keep a list of them to show to your healthcare provider and pharmacist when you get a new medicine. What are the possible side effects of BLUJEPA? BLUJEPA can cause serious side effects, including: · See the “What is the most important information I should know about BLUJEPA?” The most common side effects of BLUJEPA include: - diarrhea - nausea - stomach pain - gas - headache - soft stools - dizziness - vomiting - yeast infections These are not all the possible side effects of BLUJEPA. Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088. Please see the full Prescribing Information, including Medication Guide, for BLUJEPA. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. You may also report negative side effects to GSK at gsk.public.reportum.com or 1-888-825-5249.
Register
Important Safety Information: Blujepa/gepotidacin

Do not take VOQUEZNA if you:

  • are allergic to vonoprazan or any of the other ingredients in VOQUEZNA. Allergic reaction symptoms may include trouble breathing, rash, itching, and swelling of your face, lips, tongue or throat.
  • are taking a medicine that contains rilpivirine (EDURANT, COMPLERA, JULUCA, ODEFSEY) used to treat HIV-1 (Human Immunodeficiency Virus).